Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans

Infection and Immunity

Volumn 66, Issue 7, 1998, Pages 3390-3396

  Rudin, Anna ^a   Johansson, Eva Liz ^a   Bergquist, Charlotta ^a   Holmgren, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN B SUBUNIT; CHOLERA VACCINE; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ARTICLE; FEMALE; HUMAN; IMMUNE RESPONSE; INTRANASAL DRUG ADMINISTRATION; NORMAL HUMAN; NOSE SECRETION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SNEEZING; UPPER RESPIRATORY TRACT INFECTION; VACCINATION; VAGINA SECRETION; VIBRIO CHOLERAE;

EID: 0031867253     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.7.3390-3396.1998     Document Type: Article

References (38)

1. Aggerbeck, H., S. Gizurarson, J. Wantzin, and I. Heron. 1997. Intranasal booster vaccination against diphtheria and tetanus in man. Vaccine 15:307-316.
2. Aizpurua, H. J., and G. J. Russell-Jones. 1988. Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding. J. Exp. Med. 167:440-451.
3. Bergquist, C., T. Lagergård, M. Lindblad, and J. Holmgren. 1995. Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates. Infect. Immun. 63:2021-2025.
4. Bergquist, C., E.-L. Johansson, T. Lagergård, J. Holmgren, and A. Rudin. 1997. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect. Immun. 65:2676-2684.
5. Bergquist, C., E.-L. Johansson, and A. Rudin. New methods for sampling nasal and vaginal secretions in humans. Submitted for publication.
6. Bouvet, J. P., L. Bélec, R. Pirès, and J. Pillot. 1994. Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination. Infect. Immun. 62:3957-3961.
7. Brandtzaeg, P. 1985. Cells producing immunoglobulins and other immune factors in human nasal mucosa. Protides Biol. Fluids. Proc. Colloq. 32:363-366.
8. Cotter, T. W., Q. Meng, Z.-L. Shen, Y.-X. Zhang, H. Su, and H. Caldwell. 1995. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect. Immun. 63:4704-4714.
9. Crowley-Nowick, P. A., M. Bell, R. P. Edwards, D. McCallister, H. Gore, A. Kanbour-Shakir, J. Mestecky, and E. E. Partridge. 1995. Normal uterine cervix: characterization of isolated lymphocyte phenotypes and immunoglobulin secretion. Am. J. Reprod. Immunol. 34:241-247.
10. Cui, Z.-D., T. D. Tristam, L. J. LaScolea, T. Kwiatkowski, Jr., S. Kopti, and P. Ogra. 1991. Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization. Infect. Immun. 59:1465-1469.
11. Czerkinsky, C., L.-Å. Nilsson, H. Nygren, O. Ouchterlony, and A. Tarkowski. 1983. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 65:109-121.
12. Di Tommaso, A., G. Saletti, M. Pizza, R. Rappuoli, G. Dougan, S. Abrignani, G. Douce, and M. T. De Magistris. 1996. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect. Immun. 64:974-979.
13. Holm, S. Estimation and multiple comparisons when there are missing values with an application to immunology. Biometrical J., in press.
14. Holmgren, J. 1981. Actions of cholera toxin and the prevention and treatment of cholera. Nature 292:413-417.
15. Holmgren, J., and A.-M. Svennerholm. 1992. Bacterial enteric infections and vaccine development. Gastroenterol. Clin. N. Am. 21:283-302.
16. Holmgren, J., C. Czerkinsky, N. Lycke, and A.-M. Svennerholm. 1994. Strategics for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen carrier and adjuvant. Am. J. Trop. Med. Hyg. 50(Suppl.):42-54.
17. Hopkins, S., J.-P. Kraehenbuhl, F. Schödel, A. Potts, D. Peterson, P. De Grandi, and D. Nardelli-Haefliger. 1995. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect. Immun. 63:3279-3286.
18. Jertborn, M., A.-M. Svennerholm, and J. Holmgren. 1994. Immunological memory after immunization with oral cholera B subunit-whole-cell vaccine in Swedish volunteers. Vaccine 12:1078-1081.
19. Jertborn, M., A.-M. Svennerholm, and J. Holmgren. 1996. Intestinal and systemic immune responses in humans after oral immunizations with a bivalent B subunit-O1/O139 whole cell cholera vaccine. Vaccine 14:1459-1465.
20. Johansson, E.-L., C. Rask, M. Fredriksson, K. Eriksson, C. Czerkinsky, and J. Holmgren. 1998. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates. Infect. Immun. 66:514-520.
21. Kantele, A. 1990. Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine. Vaccine 8:321-326.
22. Kilhamn, J., M. Jertborn, and A.-M. Svennerholm. 1998. The kinetics of local and systemic immune responses to an oral cholera vaccine given alone or together with acetylcysteine. Clin. Diagn. Lab. Immunol. 5:247-250.
23. Kozlowski, P. A., S. Cu-Uvin, M. R. Neutra, and T. P. Flanigan. 1997. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect. Immun. 65:1387-1394.
24. Kutteh, W. H., and J. Mestecky. 1994. Secretory immunity in the female reproductive tract. Am. J. Reprod. Immunol. 31:40-46.
25. Lewis, D. J. M., P. Novotny, G. Dougan, and G. E. Griffin. 1991. The early cellular and humoral immune response to primary and booster oral immunisation with cholera toxin B subunit. Eur. J. Immunol. 21:2087-2094.
26. Mestecky, J. 1987. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 7:265-276.
27. Moldoveanu, Z., M. L. Clements, S. J. Prince, B. R. Murphy, and J. Mestecky. 1995. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine 13:1006-1012.
28. Ogra, P. L., and D. T. Karzon. 1969. Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine. J. Immunol. 102:1423-1430.
29. Ogra, P. L., D. T. Karzon, F. Righthand, and M. MacGillivray. 1968. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. N. Engl. J. Med. 279:893-900.
30. Parr, M. B., and E. L. Parr. 1994. Mucosal immunity in the female and male reproductive tracts, p. 677-689. In P. L. Ogra, M.-E. Lamm, J. R. McGhee, J. Mestecky, W. Strober, and J. Bienenstock (ed.), Handbook of mucosal immunology. Academic Press, San Diego, Calif.
31. Quiding-Järbrink, M., G. Granström, I. Nordström, J. Holmgren, and C. Czerkinsky. 1995. Induction of compartmentalized B-cell responses in the human tonsils. Infect. Immun. 63:853-857.
32. Russell, M. W., Z. Moldoveanu, P. L. White, G. J. Sibert, J. Mestecky, and S. M. Michalek. 1996. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the cholera toxin B subunit. Infect. Immun. 64:1272-1283.
33. Sanchez, J., and J. Holmgren. 1989. Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholera as a basis for vaccine development. Proc. Natl. Acad. Sci. USA 86:481-485.
34. Svennerholm, A.-M., and J. Holmgren. 1978. Identification of Escherichia coli heat-labile enterotoxin by means of a ganglioside immunosorbent assay (GM1-ELISA) procedure. Curr. Microbiol. 1:19-23.
35. Svennerholm, A.-M., M. Jertborn, L. Gothefors, A. M. M. M. Karim, D. A. Sack, and J. Holmgren. 1984. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit whole cell vaccine. J. Infect. Dis. 149:884-893.
36. Wassén, L., K. Schön, J. Holmgren, M. Jertborn, and N. Lycke. 1996. Local intravaginal vaccination of the female genital tract. Scand. J. Immunol. 44: 408-414.
37. Williams, R. C., and R. J. Gibbons. 1972. Inhibition of bacterial adherence by secretory immunoglobulin A: a mechanism of antigen disposal. Science 177:697-699.
38. Winner, L. S., III, J. Mack, R. Weltzin, J. J. Mekalanos, J.-P. Kraehenbuhl, and M. R. Neutra. 1991. New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholera infection. Infect. Immun. 59:977-982.